about
Role of fine-needle aspiration in the clinical management of solid organ transplant recipients: a review.High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disordersDetection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literaturePost-liver-transplant anemia: etiology and management.Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentFine-needle aspiration of posttransplant lymphoproliferative disorders: a review.Hepatic cytotoxic T-cell infiltrates in patients with peripheral T-cell proliferative diseases/lymphomas: clinicopathological and molecular analysis.Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation.Neurological complications of organ transplantation.Posttransplant T-cell lymphoma. Report of three cases and a review of the literature.Oral lesions in organ transplant patients.Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy.Primary cardiac post-transplantation lymphoproliferative disorder--T cell type: a case report and review of the literature.Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience.Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.Role of fine-needle aspiration in clinical management of transplant patients.OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection.Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients.[Current aspects of the therapy with topical calcineurin inhibitors].All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ
P2860
Q33760487-3E7599FE-7475-4EE7-A25C-88C299AD9069Q33965341-7A3D90A1-63B5-4771-8D02-503949C639BDQ33971192-D51AEF3E-E081-4A71-AF83-F86AE7C4DA27Q33974645-B469A90D-2B5B-421B-85EF-FE450565E38BQ34302121-DD30E8DF-0506-4C5F-A937-392F1E21AABEQ34371323-8A2CC9AA-F2E3-475E-85BF-3C5F91715212Q34427085-0083C815-EFB2-4C59-ADE8-8EABC96CB789Q34946254-F825137B-3054-42D9-9F5B-5B65B48786FDQ35089229-D1DB0290-463C-4FB2-9DD8-E2C510193351Q35648708-C2022C70-C1C6-4F11-8F24-5139B91645B9Q35917481-B8E07F38-2ED7-4191-AD97-ED7BD75F0E87Q36170494-31D26978-CC79-4144-89CF-8D9F1F1FBAB9Q36247193-3EED7F4C-C40F-4735-A255-5E92AA28D676Q40521455-5B5837BF-1D12-4914-BFF6-3D891A3C7745Q40582918-12DF3A17-F8BA-4BE0-8CAE-DAF3B94AA603Q40584058-3FF7C89F-EC33-457A-BE9B-C7CAA0128F18Q40642972-2FB78611-A64E-4AB5-A869-CDAC9A7659DBQ40760812-AAAAA4FF-0C84-4C48-B0C3-E9505A558107Q41557437-5018C288-864C-45B6-9902-9FAE7E889C7BQ42048053-EA321D33-44B9-4070-AD68-1E2B934CFE2BQ42539516-7FB4C1B3-3F80-42D5-A38E-A1DC1043836CQ42653025-2E8C3999-225B-4184-B0B7-61277FD9DF87Q42721151-1504E4F2-F7C6-4447-8AA8-2103221BE863Q44443198-0364F533-1B1F-4EC6-A063-0E0D78B7EEFFQ45450388-1D679448-84EE-4944-8715-7A7B3D85A469Q45613226-3B32EA38-3763-473C-AA25-052C2A411052Q45750262-9C12D1C5-C307-451F-BF23-1D037DBD56ECQ45759203-77A94125-6AFC-44BC-81BE-2128A739D726Q46687134-3B5D5CE9-C2FD-4EA0-82F8-40FB7B4D3129Q58381933-06354767-1129-4517-9D3C-6A45DBE1ABC3
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Posttransplantation lymphoproliferative disorders.
@en
type
label
Posttransplantation lymphoproliferative disorders.
@en
prefLabel
Posttransplantation lymphoproliferative disorders.
@en
P2093
P356
P1476
Posttransplantation lymphoproliferative disorders.
@en
P2093
P304
P356
10.1093/AJCP/99.3.265
P407
P577
1993-03-01T00:00:00Z